See the disclosure section below for a more nuanced discussion of when to disclose and when it is not required
Food and Drug Administration (FDA)-approved medications Mounjaro and Ozempic are currently facing lawsuits from patients who say that the combination of diabetes and weight loss drug left them with gastroparesis, more commonly known as stomach paralysis. The plaintiffs allege drug manufacturers didnt pre-warn patients about the problematic side effects
Therefore, we hypothesized that several hormonal abnormalities in GD could increase the risk of depression, and we analyzed the specific mechanism regarding hormonal abnormality of the HPT axis, insulin metabolism, and sex hormones
Peer review Peer review information Nature Catalysis thanks Mattheos Koffas, Bengt Mannervik, Boas Pucker, Dingguo Xu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work